Comparison of Generic (Rolexan) and Brand (Clexan) Forms of Enoxaparin in Critically Ill Patients: A Cross Over, Open Label, Randomized Prospective Clinical Trial
Backgrounds: Several generic forms of enoxaparin were introduced to the market after expiring the patent of Clexane. But the main problem with generic forms is its bio-equivalency with brand form as a little difference in active ingredients characteristics, could led to significant clinical differe...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Research Center for Rational Use of Drugs (RCRUD)
2020-03-01
|
Series: | Journal of Pharmaceutical Care |
Subjects: | |
Online Access: | https://jpc.tums.ac.ir/index.php/jpc/article/view/297 |